DE60234015D1 - Latentes tuberkulose-diagnostisches antigen und verwendungsmethode - Google Patents
Latentes tuberkulose-diagnostisches antigen und verwendungsmethodeInfo
- Publication number
- DE60234015D1 DE60234015D1 DE60234015T DE60234015T DE60234015D1 DE 60234015 D1 DE60234015 D1 DE 60234015D1 DE 60234015 T DE60234015 T DE 60234015T DE 60234015 T DE60234015 T DE 60234015T DE 60234015 D1 DE60234015 D1 DE 60234015D1
- Authority
- DE
- Germany
- Prior art keywords
- latent tuberculosis
- methods
- use method
- diagnostic antigen
- tuberculosis diagnostic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56955—Bacteria involved in periodontal diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26034801P | 2001-01-08 | 2001-01-08 | |
US31123501P | 2001-08-09 | 2001-08-09 | |
PCT/US2002/000309 WO2002054073A2 (en) | 2001-01-08 | 2002-01-07 | Latent human tuberculosis model, diagnostic antigens, and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60234015D1 true DE60234015D1 (de) | 2009-11-26 |
Family
ID=26947939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60234015T Expired - Lifetime DE60234015D1 (de) | 2001-01-08 | 2002-01-07 | Latentes tuberkulose-diagnostisches antigen und verwendungsmethode |
Country Status (8)
Country | Link |
---|---|
US (1) | US7105170B2 (de) |
EP (1) | EP1360498B1 (de) |
JP (1) | JP3944452B2 (de) |
AT (1) | ATE445839T1 (de) |
AU (1) | AU2002237764B2 (de) |
CA (2) | CA2689741C (de) |
DE (1) | DE60234015D1 (de) |
WO (1) | WO2002054073A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004006952A2 (en) * | 2002-07-13 | 2004-01-22 | Statens Serum Institut | Therapeutic tuberculosis vaccines |
ES2231037B1 (es) * | 2003-10-31 | 2005-12-16 | Archivel Technologies, Sl | Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos. |
FR2872579B1 (fr) * | 2004-06-30 | 2006-11-24 | Pasteur Institut | Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha |
NZ562142A (en) * | 2005-03-31 | 2009-12-24 | Univ Leiden Medical Ct | Methods and means for diagnostics, prevention and treatment of Mycobacterium infections and tuberculosis disease |
NZ597557A (en) | 2006-03-02 | 2013-10-25 | Uab Research Foundation | Mycobacterial disease detection, treatment, and drug discovery |
AU2008245901B2 (en) * | 2007-04-30 | 2014-10-16 | University Of Central Florida Research Foundation, Inc. | In vitro model of latent Mycobacterial infection |
US8058022B2 (en) | 2009-07-27 | 2011-11-15 | Indian Institute Of Science | Diagnosis and monitoring of mycobacterium tuberculosis infection |
EP2807487B1 (de) * | 2012-01-27 | 2017-11-29 | PEAS Institut AB | Verfahren zum nachweis von tuberkulose |
EP2939025B1 (de) * | 2012-12-28 | 2018-04-25 | Cellestis Limited | Zellvermittelter immunreaktionstest |
KR101552610B1 (ko) | 2013-09-24 | 2015-09-18 | 연세대학교 산학협력단 | 육아종 동물모델 및 그 제조방법 |
WO2016011280A1 (en) * | 2014-07-16 | 2016-01-21 | Tangen Biosciences, Inc. | Isothermal methods for amplifying nucleic acid samples |
EP3215260B1 (de) | 2014-11-03 | 2020-01-15 | Tangen Biosciences Inc. | Vorrichtung und verfahren für zellen-, sporen- oder viruserfassung und unterbrechung |
CN109030825A (zh) * | 2017-06-12 | 2018-12-18 | 广东体必康生物科技有限公司 | 用于特异性检测结核分枝杆菌感染的蛋白Rv2031c |
RU2702609C1 (ru) * | 2018-08-06 | 2019-10-08 | Федеральное государственное бюджетное учреждение "Новосибирский научно-исследовательский институт туберкулеза" Министерства здравоохранения Российской Федерации (ФГБУ "ННИИТ" Минздрава России) | Способ моделирования туберкулезной инфекции in vitro |
WO2020264258A1 (en) * | 2019-06-28 | 2020-12-30 | United States Government As Represented By The Department Of Veterans Affairs | Methods of producing granulomas and animal models of sarcoidosis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1750197A (en) * | 1996-01-17 | 1997-08-11 | Trustees Of Boston University | Mycobacterium antigens and methods for their detection |
JP2000508525A (ja) * | 1996-03-27 | 2000-07-11 | ザ・ジョンズ・ホプキンス・ユニバーシティー | マイコバクテリウム・チュバキュローシスの定常期ストレス応答σ因子およびその制御 |
US5700925A (en) | 1996-03-27 | 1997-12-23 | The Johns Hopkins University | DNA encoding stationary phase, stress response sigma factor from Mycobacterium tuberculosis |
US5824546A (en) | 1996-03-27 | 1998-10-20 | The Johns Hopkins University | Regulation of a sigma factor from Mycobacterium tuberculosis |
CA2276491C (en) * | 1996-12-31 | 2008-01-22 | New York University | Early detection of mycobacterial disease |
WO1999002670A1 (en) * | 1997-07-10 | 1999-01-21 | The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services | Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
EP1029053A1 (de) * | 1997-11-10 | 2000-08-23 | Statens Seruminstitut | Nukleinsäurefragmente und polypeptide von mycobacterium tuberculosis |
-
2002
- 2002-01-07 JP JP2002554720A patent/JP3944452B2/ja not_active Expired - Lifetime
- 2002-01-07 AU AU2002237764A patent/AU2002237764B2/en not_active Expired
- 2002-01-07 EP EP02704064A patent/EP1360498B1/de not_active Expired - Lifetime
- 2002-01-07 CA CA2689741A patent/CA2689741C/en not_active Expired - Lifetime
- 2002-01-07 WO PCT/US2002/000309 patent/WO2002054073A2/en active Application Filing
- 2002-01-07 DE DE60234015T patent/DE60234015D1/de not_active Expired - Lifetime
- 2002-01-07 US US10/250,930 patent/US7105170B2/en not_active Expired - Lifetime
- 2002-01-07 AT AT02704064T patent/ATE445839T1/de not_active IP Right Cessation
- 2002-01-07 CA CA2433069A patent/CA2433069C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1360498B1 (de) | 2009-10-14 |
WO2002054073A2 (en) | 2002-07-11 |
JP3944452B2 (ja) | 2007-07-11 |
EP1360498A2 (de) | 2003-11-12 |
AU2002237764B2 (en) | 2007-08-23 |
WO2002054073A3 (en) | 2003-08-28 |
CA2433069C (en) | 2010-03-30 |
US7105170B2 (en) | 2006-09-12 |
ATE445839T1 (de) | 2009-10-15 |
CA2433069A1 (en) | 2002-07-11 |
US20040146933A1 (en) | 2004-07-29 |
CA2689741C (en) | 2013-10-01 |
CA2689741A1 (en) | 2002-07-11 |
JP2005506512A (ja) | 2005-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60234015D1 (de) | Latentes tuberkulose-diagnostisches antigen und verwendungsmethode | |
HUP0500444A2 (hu) | HCV antigén/ellenanyag-kombinációs esszé | |
TW200512457A (en) | Method of diagnosing SARS corona virus infection | |
BR0207067A (pt) | Método para identificar, isolar e produzir antìgenos para um patógeno especìfico e uso do mesmo | |
HUP0303134A2 (hu) | HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására | |
DE602004020489D1 (de) | Verfahren, kits und zusammensetzungen zur entwicklung und anwendung von für antigene niedriger immunogenizität spezifischen monoklonalen antikörpern | |
EA200700345A1 (ru) | Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело | |
DE69638024D1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
Whelan et al. | Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide | |
BR0011449A (pt) | Método para detectar sìfilis usando antìgenos sintéticos | |
WO2006138324A3 (en) | Treponema pallidum antigens for vaccine development and diagnostic tests | |
ES2141348T3 (es) | Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo. | |
PT946874E (pt) | Diagnostico de helicobacter pylori | |
DE602005026688D1 (de) | Toleranzstudienverfahren bei mhc-ii-transgenen tieren | |
FI20012603A0 (fi) | Diagnostinen menetelmä | |
ATE254137T1 (de) | ßLIGAND PRESENTING ASSEMBLYß (LPA), VERFAHREN ZU DESSEN HERSTELLUNG UND VERWENDUNGEN | |
ATE212129T1 (de) | Präsentation von aus lipoarabinomannan bestehenden antigenen an t-zellen durch cd1 moleküle | |
CA2276491A1 (en) | Early detection of mycobacterial disease | |
BR0314166B8 (pt) | teste de hcv | |
ATE403867T1 (de) | Evaluierung adjuvanshaltiger impfstoffe | |
ATE429440T1 (de) | Formen prostataspezifischer antigene und verfahren zu deren nachweis | |
NO20054142D0 (no) | In vitro diagnostisk test for enterovirale infeksjoner | |
ATE206138T1 (de) | Helicobacter pylori antigen | |
WO2003076570A3 (en) | Antigens and their use as diagnostics and vaccines against species of plasmodium | |
JP7401457B2 (ja) | ワクチンの効力を決定するための方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |